K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
Ostrem, J.M., Peters, U., Sos, M.L., Wells, J.A., Shokat, K.M.(2013) Nature 503: 548-551
- PubMed: 24256730 
- DOI: 10.1038/nature12796
- Primary Citation of Related Structures:  
4L8G, 4L9S, 4L9W, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4LYJ, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22 - PubMed Abstract: 
Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally associated with poor response to standard therapies. Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites ...